Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes management Dysgeusia (taste disturbance) is not listed in the UK Summary of Product Characteristics for Ozempic Potential contributing factors include gastrointestinal side effects, dehydration, concurrent medications, vitamin B12 deficiency, or oral health issues Management includes good oral hygiene, dietary modifications, staying hydrated, and reviewing concurrent medications with your healthcare provider Contact your GP if metallic taste persists beyond 23 weeks, affects nutritional intake, or accompanies other concerning symptoms Alternative diabetes medications include other GLP-1 agonists, SGLT2 inhibitors, DPP-4 inhibitors, or insulin therapy as recommended by NICE guidance Table of Contents What Causes Metallic Taste When Taking Ozempic
Preclinical studies have shown that ARA-290 reduces infarct size and preserves cardiac function in ischemia-reperfusion models protecting cardiomyocytes from the secondary damage that occurs when blood flow is restored after ischemia
It is generally used for: Weight management in adults with a BMI of 30 or higher Weight management in adults with a BMI of 28 or higher who have weight-related conditions such as type 2 diabetes or hypertension By reducing fat absorption, Orlistat lowers the number of calories your body takes in from food
Get ready to transform yourself
